Collaborative Fund Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,331
Closed -$523K – 212
2026
Q2
$523K Sell
9,331
-5,772
-38% -$300K 0.3% 93
2026
Q1
$724K Buy
+15,103
New +$661K 0.45% 76

Other funds holding RPRX

Collaborative Fund Advisors's RPRX Position: Q3 2026 in Review

Collaborative Fund Advisors sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 9,331 shares — an estimated $523K sold.

Collaborative Fund Advisors first reported a position in RPRX in Q1 2026 and held it in 2 quarters. The position peaked at $724K in Q1 2026. 703 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Collaborative Fund Advisors reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Collaborative Fund Advisors sold 9,331 Royalty Pharma shares in Q3 2026, an estimated $523K.
  • Collaborative Fund Advisors first reported a position in Royalty Pharma in Q1 2026 and held it in 2 quarters.
  • Collaborative Fund Advisors's Royalty Pharma position peaked at $724K in Q1 2026.
  • 703 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.